|Bid||12.87 x 300|
|Ask||13.87 x 1000|
|Day's Range||11.83 - 13.98|
|52 Week Range||3.82 - 16.94|
|PE Ratio (TTM)||-9.29|
|Earnings Date||Aug 2, 2017 - Aug 7, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||14.25|
GlycoMimetics, Inc. announced today the appointment of Patricia S. Andrews, chief executive officer and director of Boston Biomedical, Inc., to its Board of Directors.
NEW YORK, NY / ACCESSWIRE / June 7, 2017 / U.S. markets fell for the second consecutive day on geopolitical concerns. Inventors appear to be cautious ahead of upcoming events such as the U.K. general election, ...
GlycoMimetics, Inc. today announced that Chief Executive Officer Rachel King will provide a company overview at the Jefferies 2017 Global Healthcare Conference in New York City, on Wednesday, June 7, 2017, at 2:00 p.m.